Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check5 days agoChange DetectedA new version entry (91) dated 2026-07-02 and a separate 'Study Status' note dated 2026-07-06 were added to the history, while a 2026-06-05 entry was removed from the history.SummaryDifference0.2%

- Check12 days agoChange DetectedThe history list now displays Revision: v3.6.3, replacing Revision: v3.6.2. This indicates a new iteration of the record history.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page history shows the site revision updated from v3.6.0 to v3.6.2, indicating a newer UI version in the Record History. This update does not alter study data or listings.SummaryDifference0.0%

- Check34 days agoChange DetectedRecruitment status updated to not currently enrolling participants. The record's revision tag was updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page history now reflects a new revision label (v3.5.5) replacing the previous v3.5.4, indicating an updated version of the record.SummaryDifference0.0%

- Check62 days agoChange DetectedA new history entry dated 2026-05-08 adds a Study Status update and Revision: v3.5.4 to the record history. The prior Revision: v3.5.3 entry from 2026-04-13 has been removed.SummaryDifference0.2%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.